QUANTITATIVE CORRELATION BETWEEN THE RESIDUAL ACTIVITY OF BETA-HEXOSAMINIDASE-A AND ARYLSULFATASE-A AND THE SEVERITY OF THE RESULTING LYSOSOMAL STORAGE DISEASE

被引:262
作者
LEINEKUGEL, P [1 ]
MICHEL, S [1 ]
CONZELMANN, E [1 ]
SANDHOFF, K [1 ]
机构
[1] UNIV BONN, INST ORGAN CHEM & BIOCHEM, GERHARD DOMAGK STR 1, W-5300 BONN 1, GERMANY
关键词
D O I
10.1007/BF00219337
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
A previously suggested model for the correlation between residual activity of a lysosomal enzyme and the turnover rate of its substrate(s) has been extended to a discussion of substrate accumulation rates in individual cells and whole organs. With these considerations, much of the observed variability in age of onset and clinical phenotype, as well as the phenomenon of pseudo-deficiency, can be understood as the consequences of small differences in the residual activity of the affected enzyme. In order to experimentally verify the basic assumptions on which this model rests, studies were performed in cell culture. The radiolabeled substrates ganglioside G(M2) and sulfatide were added to cultures of skin fibroblasts with different activities of beta-hexosaminidase A or arylsulfatase A, respectively, and their uptake and turnover measured. In both series of experiments, the correlation between residual enzyme activity and the turnover rate of the substrate was essentially as predicted: degradation increased steeply with residual activity, to reach the control level at a residual activity of approximately 10-15% of normal. All cells with an activity above this critical threshold had a normal turnover. Comparison of the results of these feeding studies with the clinical status of the donor of each cell line basically confirmed our notions but also revealed the limitations of the cell culture approach.
引用
收藏
页码:513 / 523
页数:11
相关论文
共 42 条
[1]   ENZYME-LINKED IMMUNOSORBENT-ASSAY FOR THE GANGLIOSIDE GM2-ACTIVATOR PROTEIN - SCREENING OF NORMAL HUMAN-TISSUES AND BODY-FLUIDS, OF TISSUES OF GM2 GANGLIOSIDOSIS, AND FOR ITS SUBCELLULAR-LOCALIZATION [J].
BANERJEE, A ;
BURG, J ;
CONZELMANN, E ;
CARROLL, M ;
SANDHOFF, K .
HOPPE-SEYLERS ZEITSCHRIFT FUR PHYSIOLOGISCHE CHEMIE, 1984, 365 (03) :347-356
[2]  
BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911
[3]  
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[4]  
CONZELMANN E, 1987, METHOD BIOCHEM ANAL, V32, P1
[5]   PARTIAL ENZYME DEFICIENCIES - RESIDUAL ACTIVITIES AND THE DEVELOPMENT OF NEUROLOGICAL DISORDERS [J].
CONZELMANN, E ;
SANDHOFF, K .
DEVELOPMENTAL NEUROSCIENCE, 1984, 6 (01) :58-71
[6]  
CONZELMANN E, 1987, METHOD ENZYMOL, V138, P792
[7]   PURIFICATION AND CHARACTERIZATION OF AN ACTIVATOR PROTEIN FOR THE DEGRADATION OF GLYCOLIPID-GM2 AND GLYCOLIPID-GA2 BY HEXOSAMINIDASE-A [J].
CONZELMANN, E ;
SANDHOFF, K .
HOPPE-SEYLERS ZEITSCHRIFT FUR PHYSIOLOGISCHE CHEMIE, 1979, 360 (12) :1837-1849
[8]   PRENATAL-DIAGNOSIS OF GM2 GANGLIOSIDOSIS WITH HIGH RESIDUAL HEXOSAMINIDASE-A ACTIVITY (VARIANT-B1 - PSEUDO AB VARIANT) [J].
CONZELMANN, E ;
NEHRKORN, H ;
KYTZIA, HJ ;
SANDHOFF, K ;
MACEK, M ;
LEHOVSKY, M ;
ELLEDER, M ;
JIRASEK, A ;
KOBILKOVA, J .
PEDIATRIC RESEARCH, 1985, 19 (11) :1220-1224
[9]  
CONZELMANN E, 1983, AM J HUM GENET, V35, P900
[10]  
FEDERICO A, 1987, NAT ASI SERIES, V150, P253